Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy
Authors:
- 29 October 2018
- journal article
- review article
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 471 (5) , 769-780
Abstract
Alterations in the coronary vascular system are likely associated with a mismatch between energy demand and energy supply and critical in triggering the cascade of events that leads to symptomatic hypertrophic cardiomyopathy. Targeting the early events, particularly vascular remodeling, may be a key approach to developing effective treatments. Improvement in our understanding of hypertrophic cardiomyopathy began with the results of early biophysical studies, proceeded to genetic analyses pinpointing the mutational origin, and now pertains to imaging of the metabolic and flow-related consequences of such mutations. Microvascular dysfunction has been an ongoing hot topic in the imaging of genetic cardiomyopathies marked by its histologically significant remodeling and has proven to be a powerful asset in determining prognosis for these patients as well as enlightening scientists on a potential pathophysiological cascade that may begin early during the developmental process. Here, we discuss questions that continue to remain on the mechanistic processes leading to microvascular dysfunction, its correlation to the morphological changes in the vessels, and its contribution to disease progression.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (PO1 HL 62426, RO1 HL 128468, T32 HL 139439)
This publication has 142 references indexed in Scilit:
- Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling proteinJournal of Molecular and Cellular Cardiology, 2011
- Relationship between leg muscle capillary density and peak hyperemic blood flow with endurance capacity in peripheral artery diseaseJournal of Applied Physiology, 2011
- Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thicknessJournal of Cardiovascular Magnetic Resonance, 2011
- How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonanceJournal of Cardiovascular Magnetic Resonance, 2010
- Myocardial Fibrosis as an Early Manifestation of Hypertrophic CardiomyopathyNew England Journal of Medicine, 2010
- Sarcomere Control Mechanisms and the Dynamics of the Cardiac CycleJournal of Biomedicine and Biotechnology, 2010
- Echocardiographic Strain Imaging to Assess Early and Late Consequences of Sarcomere Mutations in Hypertrophic CardiomyopathyCirculation: Cardiovascular Genetics, 2009
- Origins of heterogeneity in tissue perfusion and metabolismCardiovascular Research, 2008
- Mutation of the HEXIM1 Gene Results in Defects During Heart and Vascular Development Partly Through Downregulation of Vascular Endothelial Growth FactorCirculation Research, 2008
- Vascular Endothelial Growth Factor Prevents Apoptosis and Preserves Contractile Function in Hypertrophied Infant HeartCirculation, 2006